(HS multiple 150382 2025) What's Happening in Psychedelic Therapies? An Update
Tracking # 20-1325357
Course overview
After a four-decade hiatus, researchers have returned to examining the therapeutic benefits of mind-altering substances, including MDMA (ecstasy), psilocybin (mushrooms), and ketamine, which have demonstrated powerful therapeutic effects for PTSD, depression and addictions. In this workshop we will present both the currently available scientific data, and our clinical experiences with MDMA and ketamine. Psychedelics can profoundly reorganize people's experience of themselves, and lead to increased self-compassion, capacity for intimacy and emotion regulation and thereby promote a deepening and acceleration of psychotherapeutic processes. During therapy, people often can access and find peace with disavowed, "exiled" parts of themselves. Psychedelic medicines, when dosed correctly in the appropriate context, can act as powerful catalytic tools for healing, repair and new growth potentials moving healing paradigms towards wellness, resilience and self-actualization.
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling
Certified Master Social Worker
Licensed Clinical Social Worker
Licensed Marriage and Family Therapist
Licensed Mental Health Counselor
Florida Board of Psychology
Limited License Psychologist
Psychologist
Disclosure statements
Financial: Philip Wolfson is the founder and CEO of The Ketamine Research Foundation. He has an ownership interest in Progressive Therapeutics, Inc. Dr. Wolfson will address off-label uses. He has no relevant financial relationships with ineligible organizations.
Non-financial: Philip Wolfson has no relevant non-financial relationship to disclose.
Financial: Dr. Bessel van der Kolk is a professor at Boston University School of Medicine, the Director of the Trauma Center, and the National Complex Trauma Network. He receives royalties as a published author. Dr. van der Kolk receives a speaking honorarium, recording royalties, and book royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Bessel van der Kolk has no relevant non-financial relationships with ineligible organizations.
Financial: Licia Sky receives compensation as an Intuitive Energy Bodyworker and a peer counselor. She is the co-founder and CEO of Trauma Research Foundation. Licia Sky receives a speaking honorarium and recording royalties from Psychotherapy Networker and PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Licia Sky has no relevant non-financial relationships.
Financial: Dr. Gita Vaid maintains a private practice and has employment relationships with the Ketamine Training Center Faculty and Mind Medicine Australia. She receives a speaking honorarium and recording royalties from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Gita Vaid is a member of the American Psychoanalytic Association and the American Psychiatric Association.
Financial: Ronald Siegel maintains a private practice and has employment relationships with Harvard Medical School, the University of Massachusetts, and the Institute for Meditation and Psychotherapy. He receives compensation as an international presenter. Ronald Siegel receives royalties as a published author. Ronald Siegel receives a speaking honorarium and recording, and book royalties from Psychotherapy Networker and PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Ronald Siegel is a member of the American Psychological Association the Association for the Advancement of Psychology, and the Massachusetts Psychological Association.
Financial: Richard Doblin has an employment relationship with Multidisciplinary Association for Psychedelic Studies, Inc. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Richard Doblin serve on the Board of Lykos Therapeutics.
Financial: James Hopper maintains a private practice and has employment relationships with Harvard Medical School and Cambridge Health Alliance. He receives royalties as a published author. James Hopper receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: James Hopper serves on the advisory board for Callisto. He is a member of the ...